Cargando…
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics Patients
OBJECTIVE: The role of treatment with renin-angiotensin-aldosterone system blockers at the onset of COVID-19 infection is not known in the geriatric population. The aim of this study was to assess the relationship between angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme inhibit...
Autores principales: | Genet, Bastien, Vidal, Jean-Sébastien, Cohen, Adrien, Boully, Clémence, Beunardeau, Maëlle, Marine Harlé, Louise, Gonçalves, Anna, Boudali, Yasmina, Hernandorena, Intza, Bailly, Henri, Lenoir, Hermine, Piccoli, Matthieu, Chahwakilian, Anne, Kermanach, Léna, de Jong, Laura, Duron, Emmanuelle, Girerd, Xavier, Hanon, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AMDA - The Society for Post-Acute and Long-Term Care Medicine.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480334/ https://www.ncbi.nlm.nih.gov/pubmed/33138935 http://dx.doi.org/10.1016/j.jamda.2020.09.004 |
Ejemplares similares
-
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020) -
Une approche éthique de la question du confinement des personnes âgées en contexte de pandémie COVID-19 : la prévention des fragilités face au risque de vulnérabilité
por: Piccoli, M., et al.
Publicado: (2020) -
Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021) -
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020) -
Vascular risk factors, cognitve decline, and dementia
por: Duron, E, et al.
Publicado: (2008)